课题基金 / 基金详情

项目摘要

项目成果

ULRICH G HAMMERLING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Ly-6 group of alloantigens is one example of cell-surface antigen systems which are encoded by multigene families. At least five distinct Ly-6 antigens named Ly-6A, B, C, D and Th B have been identified by us and others. Decisive progress in the biochemical and serological characterization of these antigens strongly supports our working hypothesis of close structural relationships between the Ly-6 antigens. Direct support is rendered by analysis at the DNA level with the first Ly-6 cDNA probe available, which has confirmed the existence of multiple cross-hybridizing Ly-6DNA sequences in the mouse genome. The other breakthrough was the demonstration in several laboratories, including ours, that Ly-6.A antigens are important modulators allied with T cell activation, thus providing for the first time clues regarding the physiological role of Ly-6 for lymphocytes. In view of these new developments our project on the immunogenetics of Ly-6 will be redefined as follows: we will 1) Analyse the Ly-6A and related genes in detail, 2) Continue cellular immunological studies of Ly-6 using normal cells and cloned cell lines to test the hypothesis that Ly-6 is a signal modulator in cellular activation, 3) Continue the biochemical characterization of Ly-6 proteins to determine glycosylation and phosphorylation status and their form of plasma membrane association, 4) Look for Ly-6 involvement in multimolecular complexes on the cell surface, 5) Following the finding that Ly-6A is selectively induced by interferon, study modulation of Ly-6 antigen and gene expression by lymphokines on T cell, B cells and NK cells and correlate this with functional responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Pathway of Vitamin A Action.
  • 批准号:
    7469998
  • 项目类别:
  • 资助金额:
    $33.93万
  • 财政年份:
    2005
  • 负责人:
    ULRICH G HAMMERLING
  • 依托单位:
New Pathway of Vitamin A Action.
  • 批准号:
    6967756
  • 项目类别:
  • 资助金额:
    $34.76万
  • 财政年份:
    2005
  • 负责人:
    ULRICH G HAMMERLING
  • 依托单位:
New Pathway of Vitamin A Action.
  • 批准号:
    7122785
  • 项目类别:
  • 资助金额:
    $36.13万
  • 财政年份:
    2005
  • 负责人:
    ULRICH G HAMMERLING
  • 依托单位:
New Pathway of Vitamin A Action.
  • 批准号:
    7245146
  • 项目类别:
  • 资助金额:
    $34.63万
  • 财政年份:
    2005
  • 负责人:
    ULRICH G HAMMERLING
  • 依托单位:
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: